Involvement of nitric oxide in the non-adrenergic non-cholinergic neurotransmission of horse deep penile arteries: role of charybdotoxin-sensitive K(+)-channels

British Journal of Pharmacology
U SimonsenA García-Sacristán

Abstract

1. The involvement of nitric oxide (NO) and the signal transduction mechanisms mediating neurogenic relaxations were investigated in deep intracavernous penile arteries with an internal lumen diameter of 600-900 microns, isolated from the corpus cavernosum of young horses. 2. The presence of nitric oxide synthase (NOS)-positive nerves was examined in cross and longitudinal sections of isolated penile arteries processed for NADPH-diaphorase (NADPH-d) histochemistry. NADPH-d-positive nerve fibres were observed in the adventitia-media junction of deep penile arteries and in relation to the trabecular smooth muscle. 3. Electrical field stimulation (EFS) evoked frequency-dependent relaxations of both endothelium-intact and denuded arterial preparations treated with guanethidine (10(-5) M) and atropine (10(-7) M), and contracted with 10(-6) M phenylephrine. These EFS-induced relaxations were tetrodotoxin-sensitive indicating their non-adrenergic non-cholinergic (NANC) neurogenic origin. 4. EFS-evoked relaxations were abolished at the lowest frequency (0.5-2 Hz) and attenuated at higher frequencies (4-32 Hz) by the NOS inhibitor, NG-nitro-L-arginine (L-NOARG, 3 x 10(-3) M). This inhibitory effect was antagonized by the NO precursor, L...Continue Reading

References

Jan 1, 1979·Journal of Neural Transmission·J McConnellJ Wood
Jul 17, 1992·Science·A L BurnettS H Snyder
Jul 31, 1990·Biochemical and Biophysical Research Communications·L J IgnarroJ Rajfer
Jun 1, 1989·The Journal of Urology·C StiefE A Tanagho
Jan 1, 1989·Urologia Internationalis·C StiefE A Tanagho
May 1, 1989·The Journal of Histochemistry and Cytochemistry : Official Journal of the Histochemistry Society·B T Hope, S R Vincent
May 1, 1987·The Journal of Urology·T F Lue, E A Tanagho
Aug 1, 1981·Lancet·J M PolakS R Bloom
Aug 1, 1983·The Journal of Physiology·A Bowman, J S Gillespie
Jul 1, 1980·Circulation Research·S WallensteinJ L Fleiss
Apr 1, 1994·Journal of Cardiovascular Pharmacology·L E GustafssonY Elias
Jan 26, 1993·Biochemical Pharmacology·B MayerK Schmidt
Nov 24, 1994·Nature·E H GouldingS A Siegelbaum
Apr 1, 1994·The Journal of Urology·P HedlundK E Andersson
Jul 1, 1993·The American Journal of Physiology·B E RobertsonM T Nelson

❮ Previous
Next ❯

Citations

Jan 1, 1997·World Journal of Urology·K E Andersson, C G Stief
Jul 13, 2011·Naunyn-Schmiedeberg's Archives of Pharmacology·Vítor S FernandesMedardo Hernández
Nov 8, 2005·World Journal of Urology·Alberto BrigantiFrancesco Montorsi
May 4, 2005·Pharmacology & Therapeutics·Noboru TodaTomio Okamura
Feb 13, 2001·European Journal of Pharmacology·U SimonsenA C Martinez
Aug 11, 1998·European Journal of Pharmacology·P RecioA García-Sacristán
Feb 14, 2006·Nature Clinical Practice. Urology·Alberto BrigantiFrancesco Montorsi
Aug 5, 1998·British Journal of Pharmacology·G SegarraS Lluch
Jul 20, 2007·International Journal of Impotence Research·D Prieto
Jun 30, 2000·Clinical and Experimental Pharmacology & Physiology·A C MartínezS Benedito
Jul 5, 2003·Current Medical Research and Opinion·Andrea SaloniaFrancesco Montorsi
Mar 4, 2008·The Journal of Sexual Medicine·Attila KunLaszlo Pajor
Jan 21, 2006·The Journal of Sexual Medicine·Iñigo Sáenz de TejadaUlf Simonsen
Apr 19, 2008·European Journal of Pharmacology·Ana SánchezDolores Prieto
Mar 26, 2014·British Journal of Pharmacology·G Yetik-AnacakN Murat
Apr 10, 2004·Urology·José L Ruiz RubioDolores Prieto
May 17, 2005·European Journal of Pharmacology·Ana Cristina MartínezSara Benedito
Nov 24, 2004·British Journal of Pharmacology·Dolores PrietoMedardo Hernández
May 13, 1999·Neurogastroenterology and Motility : the Official Journal of the European Gastrointestinal Motility Society·D F CottrellG T Pearson
Dec 16, 2000·Journal of Cardiovascular Pharmacology·A C MartinezS Benedito
Apr 2, 2004·International Journal of Impotence Research·P RecioM Hernández
May 30, 2003·Pharmacological Reviews·Noboru Toda, Tomio Okamura
Oct 11, 2017·Frontiers in Pharmacology·Simon G Comerma-SteffensenUlf Simonsen
Jan 31, 2006·European Journal of Pharmacology·Dolores PrietoAlbino García-Sacristán

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.